As aesthetic medicine continues to evolve beyond surface-level treatments, a new category of therapies is gaining attention: peptide therapy
Phase I/II study of intrathecal administration of recombinant human hepatocyte growth factor in patients with acute spinal cord injury: a double-blind, randomized clinical trial of safety and efficacy
[27] In advanced stages the treatment begins to fail because the cell loss is so severe that the remaining ones cannot produce enough dopamine regardless of L-DOPA levels
Highlights for 2026 Enrollment in Medicare Part D stand-alone PDPs increased for 2026 to 24.9 million, up from 23.2 million in 2025, mainly due to growth in employer group plans
Studies show BPC-157 improves collagen organization, increases tensile strength, and accelerates healing in Achilles tendon models (PMID: 21030672)
Receiving distributions from partnership interests, estates, or trusts that involve capital transactions